Immunotherapy drugs that target a protein called programmed death ligand 1 (PD-L1) on the surface of cancer cells have quickly become a mainstay to treat many forms of cancer, often with dramatic results.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200421112555.htm
No comments:
Post a Comment